Cystatin C-based glomerular filtration rate estimating equations in early chronic kidney disease

Area of Science:

• Pediatric Nephrology
• Biomarker Research
• Diagnostic Accuracy Studies

Background:

• Chronic kidney disease (CKD) in children requires accurate monitoring of glomerular filtration rate (GFR).
• Traditional GFR estimation using creatinine has limitations, especially in early-stage pediatric CKD.
• Novel biomarkers like cystatin C offer potential for improved GFR assessment.

Purpose of the Study:

• To evaluate the performance of a combined cystatin C and creatinine-based equation for GFR estimation in children with early CKD.
• To compare this combined equation against equations using cystatin C or creatinine alone.
• To determine the optimal equation for GFR assessment in this pediatric population.

Main Methods:

• A diagnostic accuracy study was conducted in a tertiary-care hospital.
• One hundred children with CKD underwent GFR measurement using 99mTc diethylenetriamine pentaacetic acid (DTPA) as the gold standard.
• Regression analyses generated cystatin C-alone and combined cystatin C-creatinine equations, which were validated against the DTPA-GFR.

Main Results:

• The cystatin C-based equation demonstrated less bias (1.9 mL/min/1.73 m2) and higher accuracy (92.1%) compared to the creatinine-based equation (bias: 12.4 mL/min/1.73 m2; accuracy: 75.7%).
• The combined cystatin C and creatinine equation showed similar performance to the cystatin C-alone equation, with a bias of -1.4 mL/min/1.73 m2 and accuracy of 91.2%.
• The creatinine-based equation [0.42 x height/creatinine] was less accurate than the cystatin C-based equation.

Conclusions:

• The cystatin C-based equation is superior to the creatinine-based equation for estimating GFR in children with early CKD.
• Incorporating creatinine into the cystatin C-based equation does not enhance its performance for GFR estimation in this cohort.
• Cystatin C alone provides a more reliable GFR estimation in pediatric early CKD.